These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31899972)

  • 1. Repeatability imprecision from analysis of duplicates of patient samples and control materials.
    Kallner A; Theodorsson E
    Scand J Clin Lab Invest; 2020 May; 80(3):210-214. PubMed ID: 31899972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement repeatability profiles of eight frequently requested measurands in clinical chemistry determined by duplicate measurements of patient samples.
    Kallner A; Petersmann A; Nauck M; Theodorsson E
    Scand J Clin Lab Invest; 2020 May; 80(3):202-209. PubMed ID: 31971449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An experimental study of methods for the analysis of variance components in the inference of laboratory information.
    Kallner A; Theodorsson E
    Scand J Clin Lab Invest; 2020 Feb; 80(1):73-80. PubMed ID: 31841049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of a generally applicable model for the evaluation of uncertainty of measurement in clinical chemistry.
    Kristiansen J
    Clin Chem Lab Med; 2001 Oct; 39(10):920-31. PubMed ID: 11758604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias in clinical chemistry.
    Theodorsson E; Magnusson B; Leito I
    Bioanalysis; 2014; 6(21):2855-75. PubMed ID: 25486232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical Performance Verification of the Beckman Coulter AU5800 Clinical Chemistry Analyser Against Recognized Quality Specifications Reveals Relevance of Method Harmonization.
    Glibert B; Bourleaux V; Peeters R; Reynolds T; Vranken G
    Clin Lab; 2016; 62(1-2):57-72. PubMed ID: 27012034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical goal-setting for monitoring patients when two analytical methods are used.
    Petersen PH; Fraser CG; Westgard JO; Larsen ML
    Clin Chem; 1992 Nov; 38(11):2256-60. PubMed ID: 1424120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of analytical quality on establishing common reference intervals and their use.
    Rustad P; Hyltoft Petersen P
    Scand J Clin Lab Invest; 2004; 64(4):399-406. PubMed ID: 15223703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valid analytical performance specifications for combined analytical bias and imprecision for the use of common reference intervals.
    Hyltoft Petersen P; Lund F; Fraser CG; Sandberg S; Sölétormos G
    Ann Clin Biochem; 2018 Sep; 55(5):612-615. PubMed ID: 29310466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the combination of trueness and precision in one expression meaningful? On the use of total error and uncertainty in clinical chemistry.
    Kallner A
    Clin Chem Lab Med; 2016 Aug; 54(8):1291-7. PubMed ID: 26812796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferability of clinical laboratory data within a health care region.
    Olafsdottir E; Aronsson T; Groth T; De Verdier CH
    Scand J Clin Lab Invest; 1992 Nov; 52(7):679-87. PubMed ID: 1455162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deriving proper measurement uncertainty from Internal Quality Control data: An impossible mission?
    Ceriotti F
    Clin Biochem; 2018 Jul; 57():37-40. PubMed ID: 29605551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commutability of reference materials in clinical chemistry.
    Franzini C
    J Int Fed Clin Chem; 1993 Sep; 5(4):169-73. PubMed ID: 10146393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Certification of cholesterol measurements by the National Reference Method Laboratory Network with routine clinical specimens: effects of network laboratory bias and imprecision.
    Bennett ST; Eckfeldt JH; Belcher JD; Connelly DP
    Clin Chem; 1992 May; 38(5):651-7. PubMed ID: 1582015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method to estimate the uncertainty of measurements in a conglomerate of instruments/laboratories.
    Kallner A; Khorovskaya L; Pettersson T
    Scand J Clin Lab Invest; 2005; 65(7):551-8. PubMed ID: 16271986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art.
    Haeckel R; Wosniok W
    Clin Chem Lab Med; 2011 Apr; 49(4):623-35. PubMed ID: 21345158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metrological traceability of values for catalytic concentration of enzymes assigned to a calibration material.
    Canalias F; Camprubí S; Sánchez M; Gella FJ
    Clin Chem Lab Med; 2006; 44(3):333-9. PubMed ID: 16519608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination.
    Anckaert E; Öktem M; Thies A; Cohen-Bacrie M; Daan NM; Schiettecatte J; Müller C; Topcu D; Gröning A; Ternaux F; Engel C; Engelmann S; Milczynski C
    Clin Biochem; 2016 Feb; 49(3):260-7. PubMed ID: 26500002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism-based way to evaluate commutability of control materials for enzymatic measurements. The example of gamma-glutamyltransferase.
    Carobene A; Guerra E; Ceriotti F
    Clin Chim Acta; 2013 Sep; 424():153-8. PubMed ID: 23791769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improvement on the criterion of the state of the art to estimate the maximal allowable imprecision.
    Sebastián-Gámbaro MA; González-de-la-Presa B; Fuentes-Arderiu X
    Eur J Clin Chem Clin Biochem; 1996 May; 34(5):445-6. PubMed ID: 8790981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.